Dhivya Suryadevara resigned for “good reason” under her August 2025 contract, according to a filing with the U.S. Securities ...
Farrow was diagnosed in 2024 with mucinous adenocarcinoma, a rare type of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results